Daniel Koppelkamm

Daniel Koppelkamm, CFA, is the Founder and Managing Partner of Convergence Partners AG, a pan-European venture capital firm specializing in investments in Mental & Brain Health, Women's Health, and AI-driven drug discovery. Daniel also serves as a Business Mentor for Tech4Eva and co-founded the AguilaCondor Foundation, which aims to protect and amplify indigenous wisdom for human consciousness elevation. As a co-founder and director of Convergence Holding Limited, Daniel oversees startup cross-border acceleration activities. In addition to investment roles in various innovative companies, including Clerkenwell Health, InterAx Biotech, and neotiv, Daniel holds advanced degrees in European Business, is a Chartered Financial Analyst, and a Chartered Alternative Investment Analyst.